,,ii #aaith ,,congress #ast ,session ,s4 #afca ,,in ,,the ,,senate ,,of ,,the ,,united ,,states ,may #f1 #bjbe ,mr4 ,hawley introduced the following bill2 which was read twice and referred to the ,committee on ,health1 ,education1 ,labor1 and ,pensions ,a ,,bill ,to require the ,secretary of ,health and ,human ,services to approve a risk evaluation and mitigation strategy for mifepristone that is identical to the strategy previously approved1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,restoring ,safeguards for ,dangerous ,abortion ,drugs ,act4 #b4 ,definition ,in this ,act1 the term covered medication means mifepristone1 also known by the brand names1 ,mifeprex and ,korlym1 and the developmental code name1 ,,ru-#dhf4 #c4 ,mifepristone ,,rems 7a7 ,in general ,not later than #ij days after the date of enactment of this ,act1 the ,secretary of ,health and ,human ,services shall-- 7#a7 withdraw approval of the risk evaluation and mitigation strategy pursuant to section #eje-a of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cee-a7 for the covered medication that is in effect on the date of enactment of this ,act2 and 7#b7 approve a risk evaluation and mitigation strategy for the covered medication that is identical to the risk evaluation and mitigation strategy for such covered medication that was approved by such ,secretary in ,june #bjaa4 7b7 ,restriction ,notwithstanding any provision of section #eje-a of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cee-a71 the ,secretary of ,health and ,human ,services-- 7#a7 shall require a risk evaluation and mitigation strategy pursuant to such section #eje-a for the covered medication2 and 7#b7 may not approve a risk evaluation and mitigation strategy pursuant to such section for the covered medication that is different from the strategy described in subsection 7a77#b74 #d4 ,federal tort for harm to women caused by abortion drugs 7a7 ,definition ,in this section1 the term covered entity means a telehealth provider1 pharmacy1 or any other person who knowingly imports or transports a covered medication in interstate or foreign commerce in violation of section #adfb of title #ah1 ,united ,states ,code4 7b7 ,liability ,a covered entity shall be liable in accordance with this section to any individual who suffers bodily injury or harm to mental health 7including any physical1 psychological1 emotional1 or physiological harm7 that is attributable1 in whole or in part1 to the individual's use of a covered medication imported or transported as described in subsection 7a74 7c7 ,private right of action ,an individual who suffers bodily injury or harm to mental health that is attributable1 in whole or in part1 to the individual's use of a covered medication as described in subsection 7b7 may bring a civil action against the covered entity in an appropriate district court of the ,united ,states or a ,state court of competent jurisdiction for-- 7#a7 compensatory damages2 7#b7 punitive damages2 and 7#c7 attorney's fees and costs4 7d7 ,rules of construction ,nothing in this section shall be construed to preempt any ,state law that makes available any other remedy to an individual described in subsection 7b74 7e7 ,effective date ,this section shall take effect on the date that is #ij days after the date of enactment of this ,act4 #e4 ,ban on importation ,section #hja of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cha7 is amended-- 7#a7 in the third sentence of subsection 7a71 by inserting or is mifepristone1 after under section #efi;,d12 and 7#b7 in subsection 7d77#a71 by adding at the end the following3 7,c7 ,notwithstanding any other provision of law1 no person may import the drug mifepristone into the ,united ,states1 including by mailing such drug to individuals4 4